Professor Martine Piccart
Professor Piccart has a primary interest in breast cancer and drug development and is a leader in international research collaboration and the principal or co-principal investigator of many clinical trials, including HERA, MINDACT and ALTTO. She is co-founder and Chair of the Breast International Group (BIG), uniting 49 academic research groups from around the world and running over 30 trials under its umbrella.
BIG’s research programmes include the European Commission supported TRANSBIG consortium of 28 institutions in 11 countries (running with the EORTC the MINDACT trial) and NeoBIG, an innovative biomarker and drug development programme focused on neo-adjuvant trials.
Professor Piccart was President of ESMO (2012-2013) and ECCO (2014-2015). She is a member of the ESMO Magnitude of Clinical Benefit Scale Working Group and active in numerous professional organisations. She is a former president of EORTC and served on the ASCO Board. She is a member of the Belgian Royal Academy of Medicine and is a (co) author of more than 390 publications in peer-reviewed journals.
Ava Battles
Beata Jagielska
Birgit Bauer
Birgit Beger
Bogi Eliasen
Denis Horgan

Dominika Czarnota-Szałkowska
Donal Buggy

Dr. Miriam O’Connor
Dr. Nina Byrnes
Dr. Panos Kanavos
Dr. Rebecca Maguire
Dr. Stephen Finn

Eduard Vrdoljak
Elisabeth Kasilingam
Fred Horne
Joanne M. Hackett, PhD

Liam Doran
Lydia Makaroff
Mary Harney

Mary Maguire
Minna Hendolin, PhD
Pierre–Alain Delley

Professor Bryan Hennessy

Professor Jérôme de Sèze
Professor Sven Meuth

Professor Thomas Berger
Stanimir Hasardzhiev
Tõnu Esko, PhD
